Purvalanol B is a selective cyclin-dependent kinases (CDKs) inhibitor with IC50 values of 6, 6, 9, > 10,000, and 6 nM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E, cdk4/cyclin D1 and cdk5-p35 respectively.
More Information Supplier Page
Purvalanol B is a selective cyclin-dependent kinases (CDKs) inhibitor with IC50 values of 6, 6, 9, > 10,000, and 6 nM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E, cdk4/cyclin D1 and cdk5-p35 respectively.
More Information Supplier Page Purvalanol B is a selective cyclin-dependent kinases (CDKs) inhibitor with IC50 values of 6, 6, 9, > 10,000, and 6 nM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E, cdk4/cyclin D1 and cdk5-p35 respectively.
More Information Supplier Page 
Netupitant a potent and highly selective NK1 receptor antagonist with Ki of 0.95 nM.
More Information Supplier Page
Netupitant a potent and highly selective NK1 receptor antagonist with Ki of 0.95 nM.
More Information Supplier Page Netupitant a potent and highly selective NK1 receptor antagonist with Ki of 0.95 nM.
More Information Supplier Page Netupitant a potent and highly selective NK1 receptor antagonist with Ki of 0.95 nM.
More Information Supplier Page Netupitant a potent and highly selective NK1 receptor antagonist with Ki of 0.95 nM.
More Information Supplier Page Purvalanol B is a selective cyclin-dependent kinases (CDKs) inhibitor with IC50 values of 6, 6, 9, > 10,000, and 6 nM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E, cdk4/cyclin D1 and cdk5-p35 respectively.
More Information Supplier Page 
